Octavia Pickett-Blakely
University of Pennsylvania
Octavia Pickett-Blakely, MD, MHS is an Associate Professor of Clinical Medicine in the Division of Gastroenterology and Hepatology at the University of Pennsylvania Perelman School of Medicine.
Dr. Pickett-Blakely completed GI and Hepatology fellowship training at Johns Hopkins Hospital as well as a Master of Health Science degree in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health.
As a clinician, educator, and clinical researcher, Dr. Pickett-Blakely’s area of expertise is gastrointestinal disease –related nutrition and gastrointestinal complications of obesity. Dr. Pickett-Blakely developed and directs the Penn Center for GI Nutrition at the University of Pennsylvania Perelman Center for Advanced Medicine. She leads studies exploring the relationship between obesity and gastrointestinal disease and clinical trials in other nutritional GI diseases like celiac disease and intestinal failure. She merges her clinical expertise with her passion for educating patients and future generations of physicians about the importance of nutrition in disease prevention and management.
Appearances
DateMay 7, 2023The AGA Board Review Course held annually at DDW provides attendees with the information they need to stay current in their practice and prepare for both the ABIM recertification and initial certification exams in gastroenterology…Presenter
University of Pennsylvania
DateMay 7, 2023Enteroendocrine cells play a major role in sensing the luminal contents of the gut and communicating with other organs such as the pancreas, liver and brain. The gut-brain connection is essential in the regulation of food intake…Moderators
Mayo Foundation for Medical Education and ResearchUniversity of Pennsylvania- DateMay 8, 2023Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Presenter
Speakers
UC San Diego HealthUniversity of Pennsylvania 
DateMay 21, 2024SOCIETY: AGA Optimal nutrition is essential to health and wellness and linked to outcomes of GI and liver diseases. However, gastroenterologists are not equipped with the nutrition knowledge/resources necessary to provide holistic care for patients with digestive diseases…Moderators
University of PennsylvaniaGeorgetown University Hospital- DateMay 19, 2024
Presenter
University of Pennsylvania - DateMay 21, 2024
Presenter
University of Pennsylvania - DateMay 20, 2024BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP1RAs) are associated with delayed gastric emptying, which has raised concerns regarding the risk of adverse anesthesia events (e.g., aspiration) among GLP1RA-treated patients…
Presenter
Speakers
University of PennsylvaniaUniversity of PennsylvaniaUniversity of Cincinnati College of Medicine - DateMay 20, 2024Obesity is prevalent within the inflammatory bowel disease (IBD) population. Several studies suggest that 15%-40% of IBD patients are obese. Obesity has further been associated with higher disease activity and reduced time to flare…
Presenter
Speakers
University of PennsylvaniaUniv of Pennsylvania - DateMay 4, 2025The session will highlight new literature and controversies with indications and complications of common surgical weight loss procedures as compared to anti-obesity medications…
Moderators
University of PennsylvaniaCincinnati Children's Hospital Medical Center - DateMay 3, 2025
Speaker
University of Pennsylvania
